[EN] 2026-10-26 | From Winter Epidemic Signals to Continuity of Care: Evaluating Respiratory Preparedness

Respiratory preparedness and essential care: verified developments, Korean surveillance reanalysis, comparison-window sensitivity and operational proposals.

SCH 재난의학센터 분석 칼럼 / SCH Disaster Medicine Center — Analysis2026-10-26 · SCH-COLUMN-2026-10-26 · EN한국어 전문Illustrative photograph, not from this event: a bandage is placed after influenza vaccination, 2020. CDC / Robert Denty; photographer Lauren Bishop. Public domain; free source: CDC PHIL 24147.Developments and the central questionPreparing for a winter epidemic means more than predicting patient numbers. Even with the same number of arrivals, pressure on a hospital depends on where registration, assessment, testing, admission or discharge becomes blocked. This column begins with Korean and international developments verified on 26 October 2026; it does not announce a new major disaster. Its central question is how to interpret increasing seasonal respiratory infections and maintain both infection prevention and essential care with limited staff. Verified announcements, calculations from public data and proposals for local implementation are distinguished below.The first Korean development concerns antimicrobial stewardship. The Korea Disease Control and Prevention Agency (KDCA) release carries 26 October in its title, but its webpage creation date is 23 October; applications open on 26 October. This is therefore a policy development marking the start of applications, rather than a new infection event today. Its relevance to winter preparedness is the question of whether organizations preserve capacity to review prescribing when demand rises. The announcement alone establishes neither programme effectiveness nor the eligibility of any individual hospital.[1]The second development is the WHO Regional Office for Europe’s influenza preparedness announcement of 23 October. Emphasizing vaccination for groups at higher risk and health workers, it addresses winter respiratory-virus preparedness in Europe. It does not mean that Korea is experiencing the same epidemic magnitude in the same week. International comparisons must acknowledge possible differences in seasonality, surveillance populations and healthcare use. The transferable question is whether prevention and service preparedness proceed together, rather than whether one country’s case counts can be imported into another.[2]The third development is WHO’s 21 October publication of priority indicators for monitoring the health effects of heat exposure on pregnant women, newborns and children. It provides a framework for observing climate and health together. It is not evidence that heat is causing the current increase in Korean influenza. The relevant connection is a measurement problem: overall averages should not stand in for the experiences of vulnerable groups. Rather than applying identical indicators to different hazards, the useful discipline is to ask whose outcomes remain unmeasured.[3]The fourth item is verified background from the beginning of Korea’s season. KDCA announced an influenza advisory on 11 September. Its published data for weeks 33–36 include an outpatient influenza-like illness proportion and hospital sentinel-surveillance admission counts. This analysis recalculates that historical table. These are not real-time observations for 26 October, and no subsequent increase or decrease is inferred. The latest magnitude of influenza in Korea today cannot be established from these observations alone.[4]Evidence and applicabilityThese four developments need not form a single causal chain. The stewardship announcement concerns a programme, vaccination communication offers prevention advice, the heat publication provides a measurement framework, and the earlier Korean table records observations from a defined period. They are read together to examine what hospitals should prepare and how preparedness should be assessed. Evaluating every response through a single number can conceal important issues. Growth in demand, access to treatment, workforce burden and delays for non-infectious emergencies are different questions.The types of evidence also require separation. Official announcements establish published measures and reported aggregates, but do not automatically establish how many deaths those measures prevent. Surveillance describes patterns without identifying individual transmission pathways. Guidance organizes actions for consideration without guaranteeing identical effects in every hospital. The operational options below are proposals informed by these materials, not programmes already proven effective in Korean practice. Implementation decisions require comparison with an institution’s actual resources and applicable guidance.CDC’s summary of the United States’ 2024–2025 season illustrates why disease burden differs from simple reported counts. It presents model estimates and explicitly notes a March 2026 correction and the possibility of further updates. This column therefore does not convert US figures into expected Korean admissions.[5] CDC’s methods describe hospital sentinel surveillance and adjustments for under-detection. Observati

SCH-COLUMN-2026-10-26,EN,Influenza,ContinuityOfCare